Indivior (INDV) Scheduled to Post Earnings on Thursday

Indivior (NASDAQ:INDV) will post its quarterly earnings results before the market opens on Thursday, April 25th. Analysts expect Indivior to post earnings of $0.38 per share for the quarter. Indivior has set its FY 2024 guidance at EPS.

Indivior (NASDAQ:INDV) last announced its earnings results on Thursday, February 22nd. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.28 by $0.15. The company had revenue of $293.00 million for the quarter, compared to analysts’ expectations of $260.00 million. Indivior had a return on equity of 538.18% and a net margin of 0.18%. On average, analysts expect Indivior to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Indivior Stock Down 0.7 %

Indivior stock opened at $19.26 on Thursday. The business’s 50-day simple moving average is $20.41 and its 200 day simple moving average is $18.42. The stock has a market cap of $2.66 billion, a price-to-earnings ratio of -962.52 and a beta of 0.46. Indivior has a 12-month low of $14.38 and a 12-month high of $26.50.

Institutional Investors Weigh In On Indivior

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Indivior by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock valued at $90,081,000 after purchasing an additional 52,836 shares in the last quarter. Goldman Sachs Group Inc. acquired a new position in Indivior in the 2nd quarter valued at $83,678,000. Barclays PLC raised its holdings in Indivior by 746.6% in the 4th quarter. Barclays PLC now owns 3,093,161 shares of the company’s stock valued at $47,232,000 after acquiring an additional 2,727,791 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its holdings in shares of Indivior by 53.6% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 176,976 shares of the company’s stock worth $2,673,000 after buying an additional 61,772 shares in the last quarter. Finally, Deutsche Bank AG acquired a new position in shares of Indivior during the 3rd quarter worth $3,181,000. Institutional investors and hedge funds own 60.33% of the company’s stock.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on Indivior in a report on Wednesday, April 3rd. They set a “buy” rating and a $37.00 target price on the stock.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.